The lymphoid malignancies branch (lymb), thoracic and GI malignancies branch (tgmb), laboratory of cancer biology and genetics (lcbg) microscopy core, and the intravital microscope core (IVM) within…

Active Purchase Order Awarded Last action

Contract number
75N91025P00279
Awardee
Awarding agency
Obligated
$165,321

Award facts

Contract value 30% obligated
  • $165,320.88 Current, with exercised options
  • $545,992.04 Potential, with all options
Completion date 31% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $38,044
Original award $127,277

About this award

The National Cancer Institute (NCI), an agency within the National Institutes of Health, awarded a $545,992.04 firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on March 27, 2025, for preventative maintenance and emergency repair services for three government-owned Leica imaging devices supporting cancer research at the Center for Cancer Research in Bethesda, Maryland. The devices include a Leica Stellaris 5 confocal microscope, a Leica CellDIVE microscope, and a Leica Aperio GT450 Digital Slide Scanner, which serve the Lymphoid Malignancies Branch, Thoracic and GI Malignancies Branch, and related research operations. This contract was not set aside for any specific business category and represents a sole-source award to the original equipment manufacturer due to the proprietary nature of the equipment.

The contract extends through March 27, 2030, comprising a 12-month base period beginning April 1, 2025, followed by four optional 12-month renewal periods. Services delivered include annual preventive maintenance visits, unlimited remote technical support during business hours, on-site emergency repairs with a three-business-day response time, and provision of original equipment manufacturer replacement parts and software updates. All work will be performed by manufacturer-trained technicians on-site at the NIH Bethesda campus, with quarterly payments made in arrears. Leica Microsystems brings extensive federal experience as a specialized microscopy and laboratory equipment provider across multiple NIH institutes and other federal agencies including the Department of Veterans Affairs, Food and Drug Administration, and Department of Defense.

Description

The lymphoid malignancies branch (lymb), thoracic and GI malignancies branch (tgmb), laboratory of cancer biology and genetics (lcbg) microscopy core, and the intravital microscope core (IVM) within the center for cancer research (CCR) at the nationa

Quick answers

Who was awarded contract 75N91025P00279?

75N91025P00279 was awarded to Leica Microsystems Inc. by National Cancer Institute (National Institutes of Health) on March 27, 2025.

How much is contract 75N91025P00279 worth?

The government has obligated $165,321 on 75N91025P00279. Its potential value, with all options, is $545,992.

Was contract 75N91025P00279 competed?

The extent of competition for 75N91025P00279 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award